A detailed history of Tokio Marine Asset Management CO LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tokio Marine Asset Management CO LTD holds 35,439 shares of GILD stock, worth $3.29 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
35,439
Previous 30,697 15.45%
Holding current value
$3.29 Million
Previous $2.11 Million 41.03%
% of portfolio
0.13%
Previous 0.1%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$66.59 - $83.99 $315,769 - $398,280
4,742 Added 15.45%
35,439 $2.97 Million
Q2 2024

Jul 26, 2024

BUY
$63.15 - $72.88 $5,936 - $6,850
94 Added 0.31%
30,697 $2.11 Million
Q1 2024

May 02, 2024

SELL
$71.58 - $87.29 $86,468 - $105,446
-1,208 Reduced 3.8%
30,603 $2.24 Million
Q4 2023

Feb 02, 2024

BUY
$73.27 - $83.09 $121,921 - $138,261
1,664 Added 5.52%
31,811 $2.58 Million
Q3 2023

Nov 02, 2023

BUY
$73.94 - $80.67 $113,128 - $123,425
1,530 Added 5.35%
30,147 $2.26 Million
Q2 2023

Jul 28, 2023

BUY
$76.01 - $86.7 $133,549 - $152,331
1,757 Added 6.54%
28,617 $2.21 Million
Q1 2023

May 11, 2023

BUY
$77.31 - $88.08 $278,393 - $317,176
3,601 Added 15.48%
26,860 $2.23 Million
Q4 2022

Jan 26, 2023

BUY
$62.32 - $89.47 $133,302 - $191,376
2,139 Added 10.13%
23,259 $0
Q3 2022

Nov 10, 2022

BUY
$59.54 - $68.01 $57,337 - $65,493
963 Added 4.78%
21,120 $1.3 Million
Q2 2022

Aug 09, 2022

BUY
$57.72 - $65.01 $190,129 - $214,142
3,294 Added 19.53%
20,157 $1.25 Million
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $121,400 - $152,127
-2,096 Reduced 11.06%
16,863 $1 Million
Q4 2021

Jan 26, 2022

BUY
$64.88 - $73.64 $16,544 - $18,778
255 Added 1.36%
18,959 $1.38 Million
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $55,911 - $60,322
826 Added 4.62%
18,704 $1.31 Million
Q2 2021

Aug 12, 2021

SELL
$63.47 - $69.35 $35,860 - $39,182
-565 Reduced 3.06%
17,878 $1.23 Million
Q1 2021

May 17, 2021

SELL
$60.0 - $68.46 $594,180 - $677,959
-9,903 Reduced 34.94%
18,443 $1.19 Million
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $41,467 - $47,250
732 Added 2.65%
28,346 $1.65 Million
Q3 2020

Nov 09, 2020

SELL
$62.1 - $78.08 $3.12 Million - $3.92 Million
-50,189 Reduced 64.51%
27,614 $1.75 Million
Q2 2020

Aug 07, 2020

SELL
$72.34 - $84.0 $1.95 Million - $2.27 Million
-26,995 Reduced 25.76%
77,803 $5.99 Million
Q1 2020

May 12, 2020

BUY
$62.63 - $80.22 $73,151 - $93,696
1,168 Added 1.13%
104,798 $7.84 Million
Q4 2019

Feb 14, 2020

BUY
$61.62 - $67.78 $31,919 - $35,110
518 Added 0.5%
103,630 $6.73 Million
Q3 2019

Oct 29, 2019

BUY
$62.51 - $69.0 $1.79 Million - $1.98 Million
28,634 Added 38.45%
103,112 $6.54 Million
Q2 2019

Jul 25, 2019

BUY
$61.87 - $69.38 $304,586 - $341,557
4,923 Added 7.08%
74,478 $5.03 Million
Q1 2019

Apr 25, 2019

BUY
$62.53 - $70.05 $31,515 - $35,305
504 Added 0.73%
69,555 $4.52 Million
Q4 2018

Feb 04, 2019

BUY
$60.54 - $79.0 $19,857 - $25,912
328 Added 0.48%
69,051 $4.32 Million
Q3 2018

Oct 23, 2018

BUY
$71.28 - $78.92 $3,136 - $3,472
44 Added 0.06%
68,723 $5.31 Million
Q2 2018

Jul 18, 2018

SELL
$64.88 - $75.68 $38,019 - $44,348
-586 Reduced 0.85%
68,679 $4.87 Million
Q1 2018

May 03, 2018

SELL
$72.84 - $88.8 $211,454 - $257,786
-2,903 Reduced 4.02%
69,265 $5.22 Million
Q4 2017

Feb 05, 2018

SELL
$71.15 - $83.52 $191,678 - $225,002
-2,694 Reduced 3.6%
72,168 $5.17 Million
Q3 2017

Oct 30, 2017

SELL
$72.11 - $85.47 $741,795 - $879,229
-10,287 Reduced 12.08%
74,862 $6.07 Million
Q2 2017

Jan 11, 2018

SELL
N/A
-8,759 Reduced 9.33%
85,149 $6.03 Million
Q1 2017

Jan 11, 2018

BUY
N/A
68,255 Added 266.07%
93,908 $6.38 Million
Q4 2016

Jan 11, 2018

SELL
N/A
-9,321 Reduced 26.65%
25,653 $1.84 Million
Q3 2016

Jan 11, 2018

SELL
N/A
-5,122 Reduced 12.77%
34,974 $2.77 Million
Q2 2016

Jan 11, 2018

SELL
N/A
-3,576 Reduced 8.19%
40,096 $3.35 Million
Q1 2016

Jan 11, 2018

BUY
N/A
43,672
43,672 $4.01 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Tokio Marine Asset Management CO LTD Portfolio

Follow Tokio Marine Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.